Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Cephalon
ClinicalTrials.gov Identifier:
NCT00079482
First received: March 8, 2004
Last updated: August 23, 2011
Last verified: August 2011